DROR · XBRL financial data

Dror Ortho-Design financial statements, every fiscal year

The same tables from 8 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (DROR's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	1	3	—	—	—	—
Research and development	—	—	851	1,004	1,540	816
General and administrative	87	97	93	1,120	1,438	1,368
Total operating expenses	169	173	179	4,379	5,224	2,223
Operating income (loss)	(168)	(170)	(179)	(4,379)	(5,224)	(2,223)
Interest expense	0	0	0	—	—	—
Other income (expense)	—	—	2	90	(32)	(41)
Net income (loss)	(168)	(171)	(179)	(3,568)	(5,776)	(2,545)
Earnings per share, basic USD per share	0.00	0.00	0.00	(0.01)	(0.01)	0.00
Earnings per share, diluted USD per share	0.00	0.00	0.00	(0.01)	(0.01)	0.00
Weighted average shares, basic thousands of shares	202,309	202,309	202,309	296,664	672,511	956,997
Weighted average shares, diluted thousands of shares	202,309	202,309	202,309	296,664	672,511	956,997

Fiscal years (DROR's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	322	186	55	3,348	549	229
Accounts receivable	—	1	—	—	—	—
Prepaid and other current assets	6	—	101	114	89	10
Total current assets	328	192	60	3,462	639	239
Property and equipment, net	—	—	3	2	24	20
Total assets	328	192	60	3,464	663	259
Accounts payable	117	102	31	107	215	114
Accrued liabilities	2	2	1	—	—	—
Total current liabilities	703	737	784	297	907	2,957
Total liabilities	703	737	784	302	1,031	3,133
Accumulated deficit	(41,454)	(41,625)	(41,803)	(13,731)	(19,507)	(22,052)
Total stockholders' equity	(375)	(545)	(724)	3,162	(368)	(2,874)
Total liabilities and equity	328	192	60	3,464	663	259
Common shares outstanding (cover page) thousands of shares	202,309	202,309	202,309	495,455	956,997	976,997

Fiscal years (DROR's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(168)	(171)	(179)	(3,568)	(5,776)	(2,545)
Stock-based compensation	—	—	20	2,254	2,246	39
Net cash from operating activities	(110)	(136)	(131)	(2,362)	(2,742)	(2,058)
Purchases of property and equipment	—	—	—	—	26	1
Net cash from investing activities	—	—	—	18	(26)	(1)
Net cash from financing activities	—	—	—	4,653	—	1,750
Net change in cash	(110)	—	(1,517)	2,309	(2,798)	(321)

SIC 3843 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3843 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Dror Ortho-Design	94	not reported	(305)*	977.0M	0.3 quarters	Q2 FY26 10-QJun 30, 2026
Neuraxis	8,322	1,929	(1,030)*	12.6M	—	Q2 FY26 10-QJun 30, 2026
Allurion Technologies	5,056	2,947	(3,221)	15.0M	1.6 quarters	Q1 FY26 10-QMar 31, 2026
Positron	357	112	(1,050)*	32.8M	0.3 quarters	Q2 FY26 10-QJun 30, 2026
Vivos Therapeutics	1,774	5,153	(3,148)*	20.1M	0.6 quarters	Q2 FY26 10-QJun 30, 2026
Harvard Apparatus Regenerative Technology	351	414	(569)*	17.6M	0.6 quarters	Q2 FY26 10-QJun 30, 2026
RetinalGenix Technologies	27	not reported	(137)*	18.8M	0.2 quarters	Q2 FY26 10-QJun 30, 2026
Beyond Air	5,509	1,768	(4,946)	957,631	2.0 quarters	Q1 FY27 10-QJun 30, 2026
United Health Products	24	0	(138)*	262.7M	0.2 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.